This session is not accredited.

Relevant and reliable answers with Archer™ solid tumor assays Speakers: Michelle Mah and Corinne Piech

It can be challenging to get all the answers needed from solid tumor samples, including keeping a panel updated with newly discovered variants, getting answers from small input samples, and ensuring you’re detecting all relevant fusions. Hear lab experts from Trillium Health Partners share their experience with Archer solid tumor NGS assays, including the ability to flexibly add in panel content, ensuring partner-agnostic fusion detection, and detecting variants in low-input samples. Relevant case studies, including those from NTRK fusion research in colorectal cancer samples, will be presented.


Michelle Mah, Genome Analyst, Trillium Health Partners. Michelle Mah trained as a genetics technologist at The Michener Institute of Education at UHN. She worked as a Laboratory Technologist in the Clinical Laboratory Genetics division and in the Advanced Molecular Diagnostics Laboratory at UHN while obtaining her masters degree in Digital Biology with a Specialization in Genomic Medicine at the University of Manchester. Michelle joined the Genetics Laboratory at Trillium Health Partners in 2020 as a Genome Analyst. In her current role, she interprets the significance of variants found by microarray and high-throughput sequencing.

Corinne Piech, Genetic Technologist (MLT), Trillium Health Partners. Corinne Piech trained as a genetics technologist at The Michener Institute of Education at UHN. She has worked as an MLT in both cytogenetics and molecular genetics at Kingston General Hospital, Hamilton Health Sciences and, currently, Trillium Health Partners. In her current role, she sets up NGS assays for both hereditary and somatic cancer testing.

Event Timeslots (1)

Day 3
Not accredited